• Sign up
  • Log in
  • Basket: (0 items)
The Cure Parkinson's Trust

Help us fund research to slow, stop and reverse Parkinson’s

Donate
  • Twitter
Skip over main navigation Menu
  • Home
  • Our research
    • Our mission
    • Clinical trials
    • Projects and progress
    • Research Focused Webinars
    • 3P Seminars: The Postdoc Program
    • Improving the clinical trial process
    • Apply for funding
    • Research events
    • The Tom Isaacs Award
  • About us
    • About Parkinson's
    • People with Parkinson's
    • Our story
    • Policies, partnerships & collaborations
    • Media and brand guidelines
    • Reports & accounts
    • The Trustees
  • Help us
    • Appeals
    • Give regularly
    • Major gifts
    • Challenge events
      • Running
      • Cycling
      • Trekking
      • All challenges
    • Our supporters
      • Fundraiser News
      • Fundraiser of the Year Award
      • Fundraise
        • Fundraising tips
        • Other ways to fundraise
    • Trusts & Foundations
    • Corporates
    • Legacy & In Memoriam
  • News & events
    • News
    • All events
    • Archive news
  • Get in touch
  • Shop
  • Donate
  • Administration
    • Log in
  • Basket: (0 items)

Research

Published: 20th May, 2015

Author: Suzanne Bailey

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Prasinezumab shows signs of slowing motor symptom decline in early stage Parkinson’s

    Earlier this year the results of a major clinical trial - called the PASADENA study - were announced. The study was testing an immunotherapy treatment targeting alpha-synclein in people with Parkinson's. The results indicated that the trial had not achieved a positive result based on a predetermined measure of success, but the investigators indicated that there were ‘signals of efficacy‘ in the data and some of these were shared at the 2020 Movement Disorder Society meeting.

  • The John Black Charitable Foundation joins International Linked Clinical Trials programme as third funding partner

    The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The John Black Charitable Foundation (JBCF), to the International Linked Clinical Trials (iLCT) programme. Together, these three partners have pledged a total of USD $6.75 million to Parkinson’s research, over three years.

  • The PD-STAT/Simvastatin study results

    This week the results of a large Cure Parkinson's Trust-funded clinical trial were released. The PD-STAT study was a UK-wide, Phase II clinical trial evaluating the disease modifying potential of the cholesterol-lowering drug simvastatin in people with Parkinson's. The results indicate that the treatment does not have any impact of the progression of the condition.

  • Cure3 Exhibition raises £1 million for The Cure Parkinson's Trust

    On 5 September The Cure Parkinson’s Trust (CPT) launched the 3rd edition of Cure3, an acclaimed selling exhibition devised by Artwise Curators and kindly hosted  by Bonhams, London, to raise funds and awareness of CPT’s research into a cure for Parkinson’s. Early results from Cure3 2020 confirm that this unique selling event has now raised over £1m for The Cure Parkinson’s Trust.

Most read

  • Breakthrough in stem cell treatment for Parkinson's

    In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

  • Tom Isaacs

    We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.

  • New Evidence Suggests Parkinson's Might Not Start in The Brain

    A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...

  • Science news

    Read the latest Parkinson's science and research news here.

  • Trials - Repurposed Drugs

    Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

  • Apply for Funding

  • The NAC Trial - the facts

  • Our story

  • Diabetes Drug Potential Disease-Modifying Therapy

    The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.

  • Alpha-synuclein and Parkinson's

Tag cloud

cell replacement therapy codicil Cure diabetes direct debit flowers GDNF GLP-1 Inflammation Leicestershire Country Cricket parkinsons Parkinson's placebo present Sense Park stem cells

The Science of Parkinson's - Dr Simon Stott, Deputy Director of Research

Read more

Published: 2nd March, 2015

Updated: 4th August, 2020

Author: Jessica Wright

Science news

Read the latest Parkinson's science and research news here. Read more

Published: 2nd March, 2015

Updated: 19th August, 2020

Author: Jessica Wright

Related topics:
  • Projects and Progress

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

Published: 3rd March, 2015

Updated: 28th July, 2020

Author: Jessica Wright

Related topics:
  • Major gifts

Parkinson's Movement

Read more

Published: 3rd March, 2015

Updated: 6th July, 2020

Author:

Latest tweet

  • We are so proud to collaborate with @MichaelJFoxOrg @GarvanInstitute @shakeitupaust @ParkinsonDotOrg @ParkinsonsUK… https://t.co/nWVA9MCvtH

    23rdSeptember, 2020 @CureParkinsonsT

  • We are so proud to collaborate with @SoaniaMathur @InnovationFixer @grafaloff and Sue Buff at our International… https://t.co/V61PlzR7hw

    23rdSeptember, 2020 @CureParkinsonsT

  • We are so proud to collaborate with @ParkinsonCanada @thepalliance @NINDStrials #TheJohnBlackCharitableFoundation a… https://t.co/J08DfTNojj

    23rdSeptember, 2020 @CureParkinsonsT

Facebook

Stay in touch

  • Email us
  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Instagram
+44 (0)20 7487 3892


SIGN UP TO RECEIVE OUR NEWSLETTERS

The Cure Parkinson’s Trust is a registered charity in England & Wales (1111816) and Scotland (SCO44368)

Terms and conditions Privacy Policy Sitemap Cookie policy Accessibility


At this current time, we are working remotely and are unable to fulfill orders made via our online shop. We kindly ask that you refrain from purchasing items until normal working practices are resumed. Thank you for your patience. Please stay safe and well. From all at CPT.